IPES-CoV: Psychological Impact of Medical Evacuations on Families of Patients Admitted to Intensive Care Unit for Severe COVID-19

Sponsor
Centre Hospitalier Metropole Savoie (Other)
Overall Status
Completed
CT.gov ID
NCT05421182
Collaborator
(none)
30
1
2
7.5
4

Study Details

Study Description

Brief Summary

At the "Métropole Savoie" hospital, to deal with the daily influx of severe patients during the second wave of COVID-19, 23 patients had to be transferred away from their home city and far from their families as part of a medical evacuation (EVASAN).

The purpose of the study is to investigate whether there is an association between medical evacuations and the occurrence of psychological disorders such as post-traumatic stress, anxiety or depression occurring within 6 to 10 months in families of evacuated patients.

The investigators want to compare the prevalence of psychological disorders in the families of patients evacuated for a serious form of COVID-19 (cases) compared to that of families of patients not evacuated (controls) hospitalized for a serious form of COVID-19.

Condition or Disease Intervention/Treatment Phase
  • Other: Revised Impact of Event Scale
  • Other: Hospital Anxiety and Depression scale
  • Other: 36-Item Short Form Survey
  • Other: satisfaction survey
  • Other: semi-directed interview with trusted person on the general experience of the patient's medical evacuation
  • Other: semi-directed interview with trusted person on the general experience of hospitalization in intensive care
N/A

Detailed Description

The case group is trusted person of evacuated patient. The control group is trusted person of not evacuated patient.

The trusted person of the group control will be matched to trusted patient of the case group on :

their relationship with the patient (spouse/ascendant/descendant/other) and on criteria specific to the patient: sex, age range ( <75 years or ≥ 75 years), invasive ventilation and becoming at 3 months post COVID-19 (survivor / non survivor)

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Case-Control StudyCase-Control Study
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Psychological Impact of Medical Evacuations on Families of Patients Admitted to Intensive Care Unit for Severe COVID-19
Actual Study Start Date :
Jun 30, 2021
Actual Primary Completion Date :
Feb 14, 2022
Actual Study Completion Date :
Feb 14, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Interview of the trusted person of evacuated patient

The interview of the trusted person of evacuated patient will be done 8 months (+/-2 months) after the medical evacuation. The interview will be carried out by a psychologist or by a doctor from the ICU

Other: Revised Impact of Event Scale
to measure the affect of routine life stress,everyday traumas and acute stress
Other Names:
  • IES-R
  • Other: Hospital Anxiety and Depression scale
    to measure anxiety and depression
    Other Names:
  • HADS
  • Other: 36-Item Short Form Survey
    SF-36 is a set of generic, coherent, and easily administered quality-of-life measures.
    Other Names:
  • SF-36
  • Other: satisfaction survey
    satisfaction survey of the trusted person about the communication with ICU personal

    Other: semi-directed interview with trusted person on the general experience of the patient's medical evacuation
    interview of the trusted person about the medical evacuation : evacuation announcement;organization of the medical evacuation,; concerns related to evacuations;reception and information by the center admitting the evacuated patient; arrangements of visit, patient repatriated

    Other: Interview of the trusted person of the not evacuated patient

    The interview of the trusted person of the not evacuated patient will be done 8 months (+/-2months) after the ICU admission The interview will be carried out by a psychologist or by a doctor from the ICU.

    Other: Revised Impact of Event Scale
    to measure the affect of routine life stress,everyday traumas and acute stress
    Other Names:
  • IES-R
  • Other: Hospital Anxiety and Depression scale
    to measure anxiety and depression
    Other Names:
  • HADS
  • Other: 36-Item Short Form Survey
    SF-36 is a set of generic, coherent, and easily administered quality-of-life measures.
    Other Names:
  • SF-36
  • Other: satisfaction survey
    satisfaction survey of the trusted person about the communication with ICU personal

    Other: semi-directed interview with trusted person on the general experience of hospitalization in intensive care
    interview of the trusted person about ICU hospitalization: reception in ICU; ICU organization; concerns related to ICU hospitalization, information and communication with ICU staff, arrangements of visit, context of ICU discharge

    Outcome Measures

    Primary Outcome Measures

    1. Comparison of the prevalence of post-traumatic stress disorder, among families of patients with severe COVID-19 evacuated to another region (case) compared to families of matched patients with severe COVID-19 not evacuated to another region (controls). [at 8months (+/-2 months) after medical evacuations for the case group, and at 8 months (+/-2 months) after ICU admission for the control group]

      the post-traumatic stress disorder of the trusted person is assessed by the Impact of Event Scale - Revised (IES-R), at 8months (+/-2 months) after medical evacuations for the case group, and at 8 months (+/-2 months) after Intensive Care Unit (ICU) admission for the control group

    Secondary Outcome Measures

    1. Prevalence of anxiety and/or depression symptoms questionnaire in families of patients hospitalized with severe COVID-19. [at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19.]

      Association between medical evacuations and the occurrence of symptoms of anxiety and/or depression at 8 months in families of patients hospitalized in intensive care for a serious form of COVID19. anxiety and/or depression symptoms assessed by the Hospital Anxiety and Depresion Scale (HADS)

    2. Quality of Life in families of patients with severe COVID-19 [at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19.]

      Quality of Life assessed by Medical Outcomes Study Short Form 36 (SF-36)

    3. Satisfaction with the communication between the health care team and the family of the patient hospitalized with severe form of COVID19 [at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19.]

      satisfaction is measured using a simple digital scale,

    4. Qualitative analysis by a psychologist of a semi-structured interview of the testimony and specific experience of families at 8 months. [at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19.]

      semi-structured interview

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Trusted person of patients admitted to the Adult Intensive Care Unit (ICU) of the "Metropole Savoie"hospital

    • during the second wave of COVID-19 in France

    • for a serious form of COVID-19

    • hospitalized more than 72 hours in ICU

    the case group is trusted person of evacuated patient. the control group is trusted person of not evacuated patient.

    Non -inclusion criteria :

    Trusted Person Refusing patient Medical Evacuation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CH Metropole Savoie Chambéry France 73000

    Sponsors and Collaborators

    • Centre Hospitalier Metropole Savoie

    Investigators

    • Principal Investigator: Vincent Peigne, CH Metropole Savoie

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Metropole Savoie
    ClinicalTrials.gov Identifier:
    NCT05421182
    Other Study ID Numbers:
    • CHMS21004
    First Posted:
    Jun 16, 2022
    Last Update Posted:
    Jun 22, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 22, 2022